Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
TD Cowen analyst Joseph Giordano downgrades Xylem (NYSE:XYL) from Buy to Hold and announces $138 price target.
UBS analyst Damian Karas initiates coverage on Xylem (NYSE:XYL) with a Buy rating and announces Price Target of $165.
Baird analyst Michael Halloran maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $155 to $170.
Stifel analyst Nathan Jones maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $170 to $172.
RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $160 to $163.
Xylem reported strong Q2 results, with revenue growth of 26%, adjusted EPS of $1.09, and raised its full-year guidance.
This represents an increase from the Company's previous full-year guidance of 15 to 16 percent on a reported basis and 4 t...
